Although BC tumors with KRT20 overexpression are not suspected of being as menacing as the aggressive KRT5+ MIBC tumors, there is also strong evidence that they can exhibit increased rates of recurrence and tumor progression. The gene discussed is KRT20; the disease is breast cancer.